Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for hypertensive patients with type 2 diabetes and albuminuria
jRCT1080222094
- Sponsor
- Tohoku University
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of spironolactone in type 2 diabetes mellitus (T2DM), hypertension (HTN) and diabetic glomerulosclerosis, sponsored by Tohoku University.
02
Drugs
spironolactone
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCT1080222094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222094.